A comparison of nanoparticulate CpG immunotherapy with and without allergens in spontaneously equine asthma‐affected horses, an animal model
Abstract Introduction New therapeutic strategies to modulate the immune response of human and equine allergic asthma are still under extensive investigation. Immunomodulating agents stimulating T‐regulatory cells offer new treatment options beyond conventional symptomatic treatment or specific immun...
Main Authors: | John Klier, Sabine Geis, Jeanette Steuer, Katharina Geh, Sven Reese, Sebastian Fuchs, Ralf S. Mueller, Gerhard Winter, Heidrun Gehlen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-03-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.198 |
Similar Items
-
Immunomodulatory asthma therapy in the equine animal model: A dose‐response study and evaluation of a long‐term effect
by: John Klier, et al.
Published: (2019-09-01) -
The Dynamics of Circulating Immune Complexes in Horses with Severe Equine Asthma
by: Malwina Slowikowska, et al.
Published: (2021-04-01) -
Omalizumab Treatment in Patients with Severe Allergic Asthma
by: Tuğba Songül Tat, et al.
Published: (2017-09-01) -
Epigenetic Changes in Asthma: Role of DNA CpG Methylation
by: Da-Jeong Bae, Ph.D., et al.
Published: (2020-01-01) -
The prevalence of respiratory allergens in patients with asthma and allergic rhinitis in Ardabil province
by: Rasool Molatefi, et al.
Published: (2020-10-01)